Differential COVID-19 infection rates in children, adults, and elderly: evidence from 38 pre-vaccination national seroprevalence studies
View ORCID ProfileCathrine Axfors, View ORCID ProfileAngelo Maria Pezzullo, View ORCID ProfileDespina G. Contopoulos-Ioannidis, Alexandre Apostolatos, View ORCID ProfileJohn P.A. Ioannidis
doi: https://doi.org/10.1101/2022.06.28.22277034
Cathrine Axfors
1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA
2Dept for Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
Angelo Maria Pezzullo
1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA
3Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy
Despina G. Contopoulos-Ioannidis
1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA
4Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA
Alexandre Apostolatos
1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA
5Faculty of Medicine, Université de Montréal, Montreal, Canada
John P.A. Ioannidis
1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA
6Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics, Stanford University, Stanford, California, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted June 29, 2022.
Differential COVID-19 infection rates in children, adults, and elderly: evidence from 38 pre-vaccination national seroprevalence studies
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos-Ioannidis, Alexandre Apostolatos, John P.A. Ioannidis
medRxiv 2022.06.28.22277034; doi: https://doi.org/10.1101/2022.06.28.22277034
Differential COVID-19 infection rates in children, adults, and elderly: evidence from 38 pre-vaccination national seroprevalence studies
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos-Ioannidis, Alexandre Apostolatos, John P.A. Ioannidis
medRxiv 2022.06.28.22277034; doi: https://doi.org/10.1101/2022.06.28.22277034
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (720)
- Anesthesia (214)
- Cardiovascular Medicine (3042)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12963)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4773)
- Geriatric Medicine (441)
- Health Economics (747)
- Health Informatics (3029)
- Health Policy (1096)
- Hematology (405)
- HIV/AIDS (952)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4545)
- Nursing (242)
- Nutrition (671)
- Oncology (2365)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (515)
- Public and Global Health (7136)
- Radiology and Imaging (1587)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (505)
- Toxicology (63)
- Transplantation (218)
- Urology (187)